Back to the feed
In brief
On 06.11.2025, a person holding the function "Executive member of the board of directors / senior management" at MindMaze Therapeutics Holding SA disclosed a sale worth CHF 1’770 to SIX Exchange Regulation.
By amount, this ranks #38 of 42 management sales disclosed at MindMaze Therapeutics Holding SA over the previous 12 months.
insider24.ch
Never miss a market signal again
Create a free account
Need more? Discover the Pro plan
Pro alertsEmail and Telegram after publication
Unlimited company trackingUnlimited watchlist with the Pro plan
Monday recapYour stocks' essentials at the open
Disclosure detail
A executive member of the board of directors / senior management of MindMaze Therapeutics Holding SA declared a "Sale" transaction on 06.11.2025.
SIX publishes the manager's function, never their name: no individual is named in management transactions.
Transaction date06.11.2025
Issuing companyMindMaze Therapeutics Holding SA
ISINCH1251125998
Transaction sideSale
Management functionExecutive member of the board of directors / senior management
Security typeRegistered shares
Quantity600
Unit priceCHF 2.95
AmountCHF 1’770
ExchangeXSWX
Notification IDT1PB600060
Other MindMaze Therapeutics Holding SA insider transactions
- Sale · Non-executive member of the board of directors14.09.2026CHF 10’140
- Sale · Non-executive member of the board of directors19.01.2026CHF 61’606
- Sale · Non-executive member of the board of directors05.01.2026CHF 158’417
- Sale · Non-executive member of the board of directors23.12.2025CHF 146’250
- Sale · Non-executive member of the board of directors22.12.2025CHF 152’504
These figures aggregate public disclosures. They are not investment advice.